Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript

Mar 21, 2023 / 04:45PM GMT
Release Date Price: $14.18 (-0.42%)
Paul Richard Knight
KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst

Hi, this is Paul Knight, the analyst at KeyBanc on life science tools, covering Maravai. It's a pleasure today to have Carl Hull talking about business in the world of mRNA and related programs. So welcome to the conference, Carl.

Carl W. Hull
Maravai LifeSciences Holdings, Inc. - Co-Founder and Executive Chairman & Interim CEO

Well, thank you, Paul. It's good to be with you.

Paul Richard Knight
KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst

If you want to make a couple of opening comments, that's great, and you can start with why is the rain in California, but...

Carl W. Hull
Maravai LifeSciences Holdings, Inc. - Co-Founder and Executive Chairman & Interim CEO

Well, you mean an atmospheric rivers are the problem the reason. No, look, I'm happy to field any questions or give your audience an overview of Maravai, whichever way you'd like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot